Marker Therapeutics Inc (MRKR)

[Marv79]

My understanding after being involved with the company on a very long term basis, Glynn has learned to temper his enthusiasm and received some coaching from major investors. Additionally, the company has enlisted Bonfiglio to execute the clinical trials. As a result, there is reasonable potential to assume this top line revenue can be realized in 2018, very good news. Wilson would not communicte the above unless all was going very well in the trials. Given all the execution and good news over the last six months, it is time to be proactive and positive and not question CEO communications to the market. I really do not think you are privy to any schedule for TPIV, I think I will listen to Wilson/Binfiglio.